INNOVIVA, INC. Cash Equivalents, at Carrying Value
INNOVIVA, INC. (INVA) had Cash Equivalents, at Carrying Value of $9.71 million as of 2012-03-31, per its 10-Q filed 2012-05-02.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2012-05-02
- 2012-03-31: Cash Equivalents, at Carrying Value $9.71M.
- 2011-12-31: Cash Equivalents, at Carrying Value $38.72M.
- 2010-12-31: Cash Equivalents, at Carrying Value $157.15M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2012-03-31 | $9.71M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $38.72M 10-Q · filed 2012-05-02 |
| 2010-12-31 | $157.15M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |